DI MUZIO, NADIA GISELLA
 Distribuzione geografica
Continente #
EU - Europa 884
NA - Nord America 767
AS - Asia 84
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
SA - Sud America 2
Totale 1.746
Nazione #
US - Stati Uniti d'America 762
SE - Svezia 594
IT - Italia 163
FI - Finlandia 49
CN - Cina 42
IE - Irlanda 29
DE - Germania 21
SG - Singapore 13
NL - Olanda 12
IN - India 9
IR - Iran 9
EU - Europa 7
HK - Hong Kong 5
CA - Canada 4
ES - Italia 4
BE - Belgio 3
AT - Austria 2
BR - Brasile 2
CH - Svizzera 2
FR - Francia 2
GB - Regno Unito 2
JP - Giappone 2
TH - Thailandia 2
AU - Australia 1
CZ - Repubblica Ceca 1
JO - Giordania 1
MN - Mongolia 1
MX - Messico 1
NZ - Nuova Zelanda 1
Totale 1.746
Città #
Lawrence 203
Princeton 201
Ashburn 132
Milan 74
New York 64
Helsinki 49
Shanghai 42
Dublin 29
Rome 17
Washington 10
Los Angeles 9
Pune 9
West Jordan 8
Seattle 7
Borås 6
Meppel 6
Singapore 6
Abbotsford 3
Bologna 3
Caserta 3
Genoa 3
Hanover 3
Oshnaviyeh 3
Santa Clara 3
Vicenza 3
Andover 2
Aprilia 2
Bangkok 2
Bari 2
Bergamo 2
Berlin 2
Beveren 2
Castenaso 2
Ferrara 2
Francavilla al Mare 2
Hong Kong 2
Jena 2
Kish 2
Lissone 2
Mestre 2
Mountain View 2
Pavia 2
Perugia 2
Pregassona 2
Tokyo 2
Vienna 2
Amman 1
Augusta 1
Boardman 1
Cagliari 1
Campodolcino 1
Central District 1
Chicago 1
Civitavecchia 1
Council Bluffs 1
Curitiba 1
Elmendorf 1
Gothenburg 1
Heeze 1
Leawood 1
Liège 1
London 1
Mexico City 1
Napoli 1
Pinehaven 1
Provo 1
Ravenna 1
Redwood City 1
Rockville 1
Salvador 1
San Francisco 1
San Mateo 1
Sarre 1
Senago 1
Shatin 1
Sydney 1
Temecula 1
Tione di Trento 1
Villanova d'Asti 1
Vimodrone 1
Zanjan 1
Totale 973
Nome #
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 39
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 38
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 33
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 29
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 28
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 28
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors 25
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 23
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 22
Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016 21
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 21
Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases 21
La qualità della vita del paziente col tumore alla prostata sottoposto a trattamento radioterapico: uno studio prospettico 20
Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index 20
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 18
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 17
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 17
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells 17
A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in rats 17
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 16
Health-related quality of life 24 months after prostate cancer diagnosis: An update from the Pros-IT CNR prospective observational study 16
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study 16
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 15
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 15
Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review 15
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 15
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 14
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. 14
A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer 14
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 14
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy 14
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 14
Defining the Right State for a Will Rogers Phenomenon in Oligometastatic Prostate Cancer 14
Patients with Cardiac Implantable Electronic Device Undergoing Radiation Therapy: Insights from a Ten-Year Tertiary Center Experience 13
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study 13
A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer 13
Re: Daniel E. Spratt, Herbert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71;37–43: High-dose Radiotherapy and Pelvic Lymph Nodal Irradiation for High-risk Prostate Cancer in the Image-guided Radiotherapy Era 13
Quality indicators in the intensity modulated/image-guided radiotherapy era 13
Hypofractionated 4D-PET/CT-based helical tomotherapy for the treatment of lung metastases: A feasibility study 13
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 13
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study 12
Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer? 12
The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT contribute to understand the link? 12
Hematologic Toxicity in Patients Treated With Postprostatectomy Whole-Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study 12
Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 12
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 12
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 12
Ocular leukemic mass-like relapse treated with CyberKnife stereotactic radiosurgery 12
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial 12
PET/CT for radiotherapy: image acquisition and data processing 11
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 11
Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas 11
Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation 11
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study 11
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer 11
Early volume variation of positive lymph nodes assessed by in-room mega voltage CT images predicts risk of loco-regional relapses in head and neck cancer patients treated with intensity-modulated radiotherapy 11
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration 11
Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges 11
Clinical implementation of low-dose total body irradiation using topotherapy technique 11
Oligometastatic disease in prostate cancer, a continuously changing paradigm: Patient selection and treatment strategy 11
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 11
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 10
Significant reduction of acute toxicity following pelvic irradiation with Helical Tomotherapy in patients with localized prostate cancer 10
ADJUVANT RADIOTHERAPY LEADS TO SUPERIOR BIO-CHEMICAL RECURRENCE FREE SURVIVAL COMPARED TO EARLY SALVAGE RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER: RESULTS OF A MATCHED-CONTROLLED MULTI-INSTITUTIONAL ANALYSIS 10
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 10
Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy 10
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 10
Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy 10
Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison 10
Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy 10
Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: case report and literature review 10
Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review 10
Physics aspects of prostate tomotherapy: planning optimization and image-guidance issues 10
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 10
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 10
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 10
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 10
Knowledge-based automatic optimization of adaptive early-regression-guided VMAT for rectal cancer 10
Reply to Salvador Vale's Letter to the Editor re: Cesare Cozzarini. Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisfactory Treatment? Eur Urol 2017;71:44–5. Preclinical Combinatory Approach to Enhance Radiotherapy Effects and Reduce its Morbidity may be Tested in the Clinic: Wider Whole-pelvis Radiotherapy Fields and Enhanced Antitumoral Effect Mediated by T Lymphocytes: A Legitimate Hypothesis? 10
Skin Dose Variations during Tomotherapy for Head and Neck Cancer Patients: Need for Adaptive Replanning? 10
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 10
Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis 9
Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy 9
IL GLEASON SCORE PATOLOGICO INFLUENZA FORTEMENTE LA SOPRAVVIVENZA IN PAZIENTI CON INVASIONE DELLE VESCICOLE SEMINALI SOTTOPOSTI A PROSTATECTOMIA RADICALE E RADIOTERAPIA ADIUVANTE 9
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases 9
PET/CT guided helical tomotherapy in patients with locally advanced pancreatic cancer 9
Segmentation of FDG PET lung lesions based on a thresholding approach for BTV definition 9
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 9
Modeling set-up error by daily MVCT for prostate adjuvant treatment delivered in 20 fractions: Implications for the assessment of the optimal correction strategies 9
Salvage brachytherapy for local recurrence after radical prostatectomy and subsequent external beam radiotherapy 9
Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study 9
Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma 9
In Regard to Perrier et al 9
Static and rotational intensity modulated techniques for head-neck cancer radiotherapy: a planning comparison 9
Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies 9
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 9
Virtual Tangential-fields Arc Therapy (ViTAT) for whole breast irradiation: Technique optimization and validation 9
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 9
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer 8
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 8
Totale 1.360
Categoria #
all - tutte 34.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202067 4 1 0 55 0 1 0 1 0 3 1 1
2020/202182 0 0 0 15 0 50 6 1 0 0 1 9
2021/2022145 0 0 2 88 4 7 10 8 12 6 1 7
2022/20231.108 472 233 75 6 0 117 42 77 46 5 11 24
2023/2024536 11 35 59 127 46 113 22 54 18 42 9 0
Totale 1.982